243 related articles for article (PubMed ID: 7155196)
1. Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release.
Martin LL; Sanders-Bush E
Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):165-70. PubMed ID: 7155196
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of an autoreceptor modulating the release of [3H]5-hydroxytryptamine from a synaptosomal-rich spinal cord tissue preparation.
Monroe PJ; Smith DJ
J Neurochem; 1985 Dec; 45(6):1886-94. PubMed ID: 3877146
[TBL] [Abstract][Full Text] [Related]
3. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
Matsumoto I; Combs MR; Jones DJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):614-26. PubMed ID: 1738111
[TBL] [Abstract][Full Text] [Related]
4. Serotonin autoreceptor in rat hippocampus: pharmacological characterization as a subtype of the 5-HT1 receptor.
Maura G; Roccatagliata E; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):323-6. PubMed ID: 3821924
[TBL] [Abstract][Full Text] [Related]
5. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
Peroutka SJ; Snyder SH
Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
Friedman RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
[TBL] [Abstract][Full Text] [Related]
7. Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves.
Engel G; Göthert M; Müller-Schweinitzer E; Schlicker E; Sistonen L; Stadler PA
Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):116-24. PubMed ID: 6646239
[TBL] [Abstract][Full Text] [Related]
8. 5-HT3 receptors are not involved in the modulation of the K(+)-evoked release of [3H]5-HT from spinal cord synaptosomes of rat.
Williams GM; Smith DL; Smith DJ
Neuropharmacology; 1992 Aug; 31(8):725-33. PubMed ID: 1382244
[TBL] [Abstract][Full Text] [Related]
9. The putative 5-HT1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor.
Middlemiss DN
J Pharm Pharmacol; 1985 Jun; 37(6):434-7. PubMed ID: 2862270
[TBL] [Abstract][Full Text] [Related]
10. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
Maura G; Barzizza A; Folghera S; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929
[TBL] [Abstract][Full Text] [Related]
11. The serotonin autoreceptor: antagonism by quipazine.
Martin LL; Sanders-Bush E
Neuropharmacology; 1982 May; 21(5):445-50. PubMed ID: 6981071
[TBL] [Abstract][Full Text] [Related]
12. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT.
Gozlan H; El Mestikawy S; Pichat L; Glowinski J; Hamon M
Nature; 1983 Sep 8-14; 305(5930):140-2. PubMed ID: 6225026
[TBL] [Abstract][Full Text] [Related]
13. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
14. (-)-Propranolol and (+/-)-cyanopindolol are mixed agonists-antagonists at serotonin autoreceptors in the hippocampus of the rat brain.
Maura G; Ulivi M; Raiteri M
Neuropharmacology; 1987 Jul; 26(7A):713-7. PubMed ID: 3627379
[TBL] [Abstract][Full Text] [Related]
15. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
Galzin AM; Moret C; Verzier B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
[TBL] [Abstract][Full Text] [Related]
16. Selective 5-HT1B agonists identify the 5-HT autoreceptor in lumbar spinal cord of rat.
Murphy RM; Zemlan FP
Neuropharmacology; 1988 Jan; 27(1):37-42. PubMed ID: 3352865
[TBL] [Abstract][Full Text] [Related]
17. Identification of multiple binding sites for [3H]5-hydroxytryptamine in the rat CNS.
Blurton PA; Wood MD
J Neurochem; 1986 May; 46(5):1392-8. PubMed ID: 3958711
[TBL] [Abstract][Full Text] [Related]
18. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
[TBL] [Abstract][Full Text] [Related]
19. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum.
Raiteri M; Maura G; Bonanno G; Pittaluga A
J Pharmacol Exp Ther; 1986 May; 237(2):644-8. PubMed ID: 2871177
[TBL] [Abstract][Full Text] [Related]
20. Diurnal variation in the function of serotonin terminals in the rat hypothalamus.
Blier P; Galzin AM; Langer SZ
J Neurochem; 1989 Feb; 52(2):453-9. PubMed ID: 2911025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
